Opinion|Videos|October 13, 2025

Unmet Needs and Barriers to Adoption of Minimally Invasive Treatments for BPH

An expert discusses how the greatest unmet need in minimally invasive benign prostatic hyperplasia (BPH) treatments is achieving durability and retreatment rates that match those of surgical options such as transurethral resection of the prostate (TURP) while maintaining sexual function preservation. He also discusses how barriers to broader adoption include inadequate technical training in office-based procedures, ongoing reimbursement challenges, and poor patient awareness because many patients and even well-meaning primary care physicians are unaware of options beyond medications or TURP.

BPH Unmet Needs and Barriers Summary

The most significant unmet need in minimally invasive BPH treatment remains durability and retreatment rates. Current excellent interventions including prostatic urethral lift, steam therapy, and nitinol stents demonstrate higher re-treatment rates than those of traditional gold-standard procedures such as TURP and HoLEP. The critical gap is developing therapies that can match the long-term surgical durability of these established procedures while preserving sexual function. The procedural kit represents progress toward addressing this challenge by encouraging urologists to place more implants per procedure, as data strongly indicate that increased implant density directly correlates with improved long-term durability of treatment outcomes.

Three primary barriers continue to limit broader adoption of minimally invasive therapies in urological practice: technical training deficiencies, reimbursement challenges, and inadequate patient awareness. Technical training represents perhaps the most significant obstacle, as most urologists lack proper instruction in comfortable office-based procedural techniques. Although urologists are competent in basic cystoscopy, there exists a crucial distinction between standard technique and performing procedures on awake patients without causing discomfort—a specialized skill requiring years of iterative refinement. Without this expertise, many practitioners avoid office-based procedures rather than risk patient suffering during extended interventions.

Reimbursement barriers affect all practice settings, from solo practitioners to large institutions and academic centers, though the new procedural kit and proposed CMS changes offer potential relief. Patient awareness remains critically limited, with many patients unaware that treatment options exist beyond medication or TURP. This knowledge gap stems partially from well-intentioned but underinformed primary care physicians who, while overworked and doing their best, lack adequate education about available minimally invasive alternatives. The problem extends to some urologists who default to escalating medical therapy rather than considering intermediate surgical options, sometimes prescribing excessive medication doses because they view the choice as simply “more medication or TURP,” missing the spectrum of available interventions that could better serve patient needs.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.


Latest CME